| 1/25/2022 | 3002120005 | BLOOD FRACTIONS NOT FOR VETERINARY, WITHOUT CONTENT. ALCOHOL, NOT FOR SALE, FOR QUALITY CONTROL OF MEDICINE , | 0.35 | 498.28 | Germany | MOSCOW RUSSIA | PHARMACTS CAPITAL LLC |
| 1/18/2022 | 3006300000 | X-RAY CONTRAST PREPARATIONS (VED): MAGNEVIST (GADOPENTETIC ACID) SOLUTION FOR INTRAVENOUS INTRODUCTION 0.5 MMOL / ML, (BOTTLE) 20ML X 10 (CARDBOARD PACK) - 513 UP, SERIES KT0B2S05 BRUTO2 YEAR.2 | 263.96 | 195305 | Germany | MOSCOW RUSSIA | BAYER JSC |
| 1/10/2022 | 3004900002 | MEDICINES FOR MEDICAL USE, FOR RETAIL (VED, V7): ESMERON (ROCURONIUM BROMIDE) SOLUTION FOR INTRAVENOUS ADMINISTRATION, 10 MG/ML (BOTTLE) 5ML X 10 (CARDBOARD PACK)-2169 UP, SERIES 4 U036968 YEAR 8.2 GROSS | 425.12 | 32950.8 | Germany | MOSCOW RUSSIA | MSD PHARMASYUTICALS LLC |
| 1/26/2022 | 3006300000 | X-RAY CONTRAST PREPARATIONS (VED): MAGNEVIST (GADOPENTETIC ACID) SOLUTION FOR INTRAVENOUS INTRODUCTION 0.5 MMOL / ML, (BOTTLE) 20ML X 10 (CARDBOARD PACK) - 3996 UE, SERIES KT0BB0L UP TO 2 SED.2 YEAR.2 | 2056.07 | 1495253.8 | Germany | MOSCOW RUSSIA | BAYER JSC |
| 1/24/2022 | 3002150000 | SAR650984 ( IZATUXIMAB), 20 MG/ML INTRAVENOUS SOLUTION CONCENTRATE IN 25 ML BOTTLE (500 MG/25 ML), 28 BOTTLE TOTAL, SERIES IP0011220, EXPIRY 12/2022, : | 1.85 | 29308.2 | Germany | Unknown | REPRESENTATIVE OFFICE OF AO SANOFI AVENTIS GROUP FRANCE |
| 1/25/2022 | 9018390000 | MEDICAL DEVICE: INTRAVENOUS DISPOSABLE STERILE VOGT MEDICAL. IT IS USED IN THE INTRODUCTION OF INTRAVENOUS INJECTIONS FOR THE INTRODUCTION OF INFUSION SOLUTIONS. OKP CODE - 94 3640, OKPD2 CODE - 32.50.13.110. | 7795.67 | 196632.7 | Germany | MOSCOW RUSSIA | PHARMACEUTICAL COMPANY MEDARGO LLC |
| 1/10/2022 | 3004900002 | RETAIL DRUG (VED, A5): CERUCALE (METHOCLOPRAMIDE) INTRAVENOUS AND INTRAMUSCULAR SOLUTION 5 MG/ML (AMPOULE) 2 ML X 10 (CARDBOARD PACK) - 12858 PK, SERIES X16164 EXPIRY WEIGHT UP TO 08.2 PALLETS | 797.2 | 29323.4 | Germany | MOSCOW RUSSIA | TEVA LLC |
| 1/21/2022 | 9018390000 | MEDICAL DEVICE: INTRAVENOUS DISPOSABLE STERILE VOGT MEDICAL. IT IS USED IN THE INTRODUCTION OF INTRAVENOUS INJECTIONS FOR THE INTRODUCTION OF INFUSION SOLUTIONS. OKP CODE - 94 3640, OKPD2 CODE - 32.50.13.110. | 8463 | 196633.3 | Germany | MOSCOW RUSSIA | PHARMACEUTICAL COMPANY MEDARGO LLC |